Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 11821
TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650928(US20240043442, Example 12)
Affinity DataIC50: 0.260nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650917(US20240043442, Example 1)
Affinity DataIC50: 0.300nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM50503111(CHEMBL4528514 | US11672785, Goodacre Compound 102 ...)
Affinity DataIC50: 0.300nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650936(US20240043442, Example 20)
Affinity DataIC50: 0.300nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM50125052(CHEMBL3623004 | US10130617, Example 1 | WO-2014/19...)
Affinity DataIC50: 0.400nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM50169743(CHEMBL1358 | (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9...)
Affinity DataIC50: 0.400nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650964(US20240043442, Example 46A | US20240043442, Exampl...)
Affinity DataIC50: 0.400nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650950(US20240043442, Example 34A)
Affinity DataIC50: 0.400nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650947(US20240043442, Example 31A)
Affinity DataIC50: 0.400nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650922(US20240043442, Example 6)
Affinity DataIC50: 0.400nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650927(US20240043442, Example 11)
Affinity DataIC50: 0.400nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650969(US20240043442, Example 49)
Affinity DataIC50: 0.5nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM50580462(CHEMBL5087025 | US20240043442, Example 21)
Affinity DataIC50: 0.5nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650929(US20240043442, Example 13A)
Affinity DataIC50: 0.5nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM288602((E)-3-(3,5-difluoro-4-((1R,3R/1S,3S)-2-(2-fluoro-2...)
Affinity DataIC50: 0.600nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650942(US20240043442, Example 26A | US20240043442, Exampl...)
Affinity DataIC50: 0.600nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650958(US20240043442, Example 41)
Affinity DataIC50: 0.600nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650919(US20240043442, Example 3)
Affinity DataIC50: 0.600nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650942(US20240043442, Example 26A | US20240043442, Exampl...)
Affinity DataIC50: 0.600nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650932(US20240043442, Example 16A)
Affinity DataIC50: 0.600nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650943(US20240043442, Example 27B)
Affinity DataIC50: 0.700nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650961(US20240043442, Example 43B)
Affinity DataIC50: 0.800nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650923(US20240043442, Example 7)
Affinity DataIC50: 0.800nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650933(US20240043442, Example 17A)
Affinity DataIC50: 0.800nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650941(US20240043442, Example 25)
Affinity DataIC50: 0.800nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650945(US20240043442, Example 29)
Affinity DataIC50: 0.900nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650956(US20240043442, Example 40A | US20240043442, Exampl...)
Affinity DataIC50: 0.900nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650920(US20240043442, Example 4)
Affinity DataIC50: 0.900nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650918(US20240043442, Example 2)
Affinity DataIC50: 0.900nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650946(US20240043442, Example 30)
Affinity DataIC50: 1nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650924(US20240043442, Example 8)
Affinity DataIC50: 1nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650949(US20240043442, Example 33A)
Affinity DataIC50: 1.20nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650944(US20240043442, Example 28)
Affinity DataIC50: 1.30nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650931(US20240043442, Example 15A)
Affinity DataIC50: 1.80nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650940(US20240043442, Example 24)
Affinity DataIC50: 1.90nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650959(US20240043442, Example 42A | US20240043442, Exampl...)
Affinity DataIC50: 1.90nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650948(US20240043442, Example 32A)
Affinity DataIC50: 1.90nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650951(US20240043442, Example 35A)
Affinity DataIC50: 2.5nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650938(US20240043442, Example 22A)
Affinity DataIC50: 2.60nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650930(US20240043442, Example 14B)
Affinity DataIC50: 2.60nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650955(US20240043442, Example 39A)
Affinity DataIC50: 2.60nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650953(US20240043442, Example 37A)
Affinity DataIC50: 2.90nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650925(US20240043442, Example 9)
Affinity DataIC50: 3.10nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650935(US20240043442, Example 19A)
Affinity DataIC50: 3.10nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650926(US20240043442, Example 10)
Affinity DataIC50: 3.20nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650939(US20240043442, Example 23 | US20240043442, Example...)
Affinity DataIC50: 4.20nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM288603((E)-3-(3,5-difluoro-4-((1R,3R/1S,3S)-2-(2-fluoro-2...)
Affinity DataIC50: 4.70nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650962(US20240043442, Example 44A)
Affinity DataIC50: 7.90nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM50090462(CHEMBL3581693 | US20240043442, Example GDC-0810 | ...)
Affinity DataIC50: 8.5nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

TargetEstrogen receptor(Human)
Inventisbio

US Patent
LigandPNGBDBM650963(US20240043442, Example 45)
Affinity DataIC50: 8.90nMAssay Description:Compound activity was analyzed using celltiter-glo luminescent viability assay (Promega #G7572) in breast cancer cell line MCF-7. Cells grown in log ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: